Clinical trial

Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With…

NCT00176995 · Hordinsky, Maria K., MD, Other · Completed

Key facts

NCT number NCT00176995
Title Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae
Official title Phase II, Open-Label Study of the Effect of 15% Eflornithine Hydrochloride Cream on Facial Hair of Men of African-American Descent With Pseudofolliculitis Barbae: A Laser Scanning Confocal Microscopy and Video Imaging Study
Lead sponsor Hordinsky, Maria K., MD, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Pseudofolliculitis Barbae
Intervention type Drug
Interventions 15% Eflornithine Hdyrochloride
Enrollment 15
Start date Mar 1, 1999
Completion Oct 1, 2000
First posted Sep 15, 2005
Last update posted Nov 13, 2006
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies